Skip to main content
Premium Trial:

Request an Annual Quote

Primera Raises $21M To Support Development of PCR-Based Dx System

NEW YORK (GenomeWeb News) - Primera Biosystems said this week that it has raised $21 million in series B financing that it will use to develop diagnostic instrument and reagent kits for clinical research.
 
The funding round was led by Abingworth and included investments from Interwest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company, and the Invus Group.
 
Primera is developing the Scalable Target Amplification Routine platform, or STAR, a bench-top quantitative real-time PCR system.
 
The company is also developing an assay to measure multiple viral agents to cause infections in immune comprised patients and a multiplex fungal test, both using the STAR system.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.